---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-063143"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2023-05-22T23:59:59+00:00"
generated_at: "2026-06-14T18:16:57.287900+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics receives Nasdaq deficiency notice for negative stockholders' equity

## Summary
- Nasdaq notified Avenue Therapeutics on May 19, 2023, of non-compliance with minimum $2.5M stockholders' equity requirement.
- Q1 2023 10-Q reported stockholders' equity of negative $2,157,000.
- Company has 45 days (until July 3, 2023) to submit a plan to regain compliance.
- No immediate effect on listing; stock continues trading on Nasdaq under ATXI.
- Company intends to submit compliance plan and take measures to regain compliance, but no assurance of success.

## SEC filing metadata
- accession: 0001104659-23-063143
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2023-05-22T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465923063143/0001104659-23-063143-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465923063143/tm2316427d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-063143
- JSON: https://secwatch.observer/filing/0001104659-23-063143.json
- Plain text: https://secwatch.observer/filing/0001104659-23-063143.txt

## Key facts
- Listing & Compliance Notices
  AVENUE THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: $2,500,000 (the “Stockholders’ Equity Requirement”). The Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2023, reported stockholders’ equity of negative $2,157,000. The Letter further noted that as of the letter date, the Company did not have a market value of listed securities of $35 million, or net income from continued operations of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465923063143/0001104659-23-063143-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.